Impact of adding abdominal circumference to the definition of fetal growth restriction

C Andrew Combs1, Ramon Castillo2, Gilbert W Webb3

  • 1Mednax Center for Research, Education, Quality and Safety, Sunrise, Florida (Dr Combs); Obstetrix Medical Group, San Jose, CA (Dr Combs and Ms del Rosario).

Insights

The Society for Maternal-Fetal Medicine

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Diagnostic Ultrasound

Background:

  • Fetal growth restriction (FGR) traditionally defined by estimated fetal weight (EFW) <10th percentile.
  • 2020 Society for Maternal-Fetal Medicine (SMFM) guideline recommended expanding FGR definition.
  • Expanded definition includes EFW <10th percentile or fetal abdominal circumference (AC) <10th percentile.

Purpose of the Study:

  • To assess the impact of adding AC <10th percentile to FGR diagnosis.
  • To compare diagnostic rates using traditional EFW <10th percentile alone versus expanded criteria.
  • To evaluate the Copel-Bahtiyar definition (EFW <10th percentile or AC <5th percentile).

Main Methods:

  • Retrospective descriptive study of 20,633 ultrasound examinations (Jan 2019-July 2020).
  • Inclusion criteria: singleton pregnancy, ≥24 weeks gestation, fetal cardiac activity, standard biometry.
  • Compared diagnostic rates for FGR using traditional, Copel-Bahtiyar, and SMFM criteria.

Main Results:

  • Traditional FGR rate (EFW <10th percentile): 9.7%.
  • Copel-Bahtiyar (EFW <10th percentile or AC <5th percentile) rate: 10.2% (P<.001 vs. traditional).
  • SMFM (EFW <10th percentile or AC <10th percentile) rate: 11.6% (P<.001 vs. traditional and Copel-Bahtiyar).

Conclusions:

  • Adding AC <10th percentile significantly increases FGR diagnosis rates.
  • The absolute increase in FGR diagnoses is small and unlikely to burden resources.
  • The SMFM definition provides a more inclusive diagnosis of FGR without significant resource implications.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.6K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
872
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.8K